Compounds for the modulation of beta-catenin expression and uses thereof
AU2011329180A1
Methods of treating cancers with HER3 and PIK3CA antisense oligonucleotides
AU2011326034A1
Compositions and methods for treating androgen receptor dependent disorders including cancers
CN102869254A
Polymeric conjugates of adenine nucleoside analogs
GB201101969D0
Methods
WO2011082368A2
Polymeric conjugates of aromatic amine containing compounds including releasable urea linker
AU2010276261A1
Methods of treating HER2 positive cancer with HER2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
CN102395370A
Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
CN102395374A
Methods of treating cancers with her3 antisense oligonucleotides
US2011230420A1
Releasable conjugates for nucleic acids delivery systems
CN102215820A
Releasable fusogenic lipids for nucleic acids delivery systems
CN102231950A
Releasable polymeric lipids for nucleic acids delivery systems
CA2742776A1
Releasable cationic lipids for nucleic acids delivery systems
AU2009313510A1
ERBB-3 (HER3)-selective combination therapy
CN102215688A
Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
TW201010732A
Method of treating RAS associated cancer
AU2009265194A1
RNA antagonists targeting Hsp27
CA2723263A1
Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides
